Neuland Laboratories Ltd. (NEULANDLAB) Share Price Rises 3.02% Today
- August 7, 2026
- Posted by: Harsh Piplani
- Category: News
Neuland Laboratories Ltd. rose to Rs 22,150, up 3.02% today, with market capitalisation at Rs 25,614.49 crore and turnover of Rs 11.33 crore.
Neuland Laboratories Ltd. Share Price moved to Rs 22,150 on 07 August 2026, up 3.02% for the day, taking the company’s market capitalisation to Rs 25,614.49 crore. That places the stock firmly on the day’s watchlist because the supplied data confirms a meaningful same-day price rise in a large-cap counter rather than a routine tick higher.
Neuland Laboratories Ltd. Share Price Today opened at Rs 21,544.2, touched a day high of Rs 22,225 and held above the previous close of Rs 21,499.95 during the session window captured in this update. The absolute gain stood at Rs 650.05. In Stock Market Today terms, that combination of a strong percentage move, a higher intraday range and turnover of Rs 11.33 crore is enough to make the stock part of the active market conversation.
The supplied data confirms the price event, but it does not establish a company-specific catalyst behind why the stock is rising today. Even so, Neuland Laboratories Ltd. Stock News becomes relevant because the move has already crossed the qualifying bar for its market-cap bucket and because trading activity reached 1,13,373 shares across exchanges. For investors tracking Top Gainers Today, the immediate questions are straightforward: what exactly happened in price action, how active was participation, and how does the stock’s size compare with the broader Healthcare sector universe. This Univest analysis addresses those verified points first, then places the move in sector and peer context so readers can judge why Neuland Laboratories Ltd. Share Price is trending in today’s Market News.
Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 22,150 |
| Previous Close | Rs 21,499.95 |
| Today's Change | +Rs 650.05 (+3.02%) |
| Day Open | Rs 21,544.2 |
| Day High | Rs 22,225 |
| Day Low | Rs 21,544.2 |
| Current Volume (BSE) | 5,113 |
| BSE Traded Volume | 5,113 |
| NSE Traded Volume | 1,08,260 |
| Combined NSE + BSE Volume | 1,13,373 |
| Turnover | Rs 11.33 crore |
| Market Capitalisation | Rs 25,614.49 crore |
| Market Cap Category | Large Cap |
Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 22,150. versus the previous close of Rs 21,499.95, a rise of 3.02%. The stock opened at Rs 21,544.2, reached Rs 22,225, touched Rs 21,544.2. Reported volume was 5,113.
Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 25,614.49 crore |
Neuland Laboratories Ltd. Fundamental Analysis, based strictly on the supplied data, begins with scale. The company’s market capitalisation stands at Rs 25,614.49 crore, which is far above the Healthcare sector snapshot’s median market capitalisation of Rs 140.58 crore and average of Rs 471.12 crore across 198 companies in the same sector benchmark. That does not by itself say anything about cheapness or quality, but it does confirm that the company sits at a much larger size point than the typical stock in the benchmark set.
That size gap matters for interpreting Neuland Laboratories Ltd. Share Price Rise. A 3.02% move in a company valued at Rs 25,614.49 crore naturally carries different market significance from a similar percentage move in a much smaller stock. In practical terms, a large-cap price rise often draws attention because more capital is required to move the stock meaningfully.
The day’s turnover of Rs 11.33 crore also adds a useful market-quality layer. Turnover reflects the rupee value of shares traded and helps investors judge whether the move was accompanied by active participation. Combined with total volume of 1,13,373 shares, the latest Neuland Laboratories Ltd. Share Price Update points to a session with visible trading interest.
From a fundamental-context perspective, the supplied data does not establish a company-specific earnings, margin, leverage, cash-flow or valuation trigger for today’s rise. That means the current Neuland Laboratories Ltd. Stock Analysis has to remain focused on what is verified: company size, price movement and comparative sector positioning. For readers following Neuland Laboratories Ltd. Financial Results or Neuland Laboratories Ltd. Earnings in a broader sense, today’s move is notable because it happened in a large-cap Healthcare name and because it stood out enough to enter a price-rise threshold screen. That makes valuation and peer context the most relevant next lens, which is where the sector comparison becomes important in this Univest review.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Benchmark Median P/E | 26.27x |
| Benchmark Average P/E | 92.32x |
| Benchmark P/E Range | 3.3x to 3,493.04x |
| Benchmark Median P/B | 1.95x |
| Benchmark Median ROE | 10.77% |
| Benchmark Median ROCE | 13.35% |
| Company Market Capitalisation | Rs 25,614.49 crore |
| Benchmark Median Market Cap | Rs 140.58 crore |
Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.
Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.
The Healthcare sector snapshot shows why today’s move in Neuland Laboratories Ltd. Share Price deserves context beyond the headline gain. The benchmark covers 198 companies in the same sector, giving a broad comparison set for valuation, profitability and market size. Against that backdrop, the company’s market capitalisation of Rs 25,614.49 crore stands dramatically above the benchmark median of Rs 140.58 crore and average of Rs 471.12 crore.
The benchmark valuation data also reveals how wide the Healthcare universe is. Among 156 companies with P/E data, the median P/E is 26.27 while the average is 92.32, with a range from 3.3 to 3,493.04. For P/B, 197 companies show a median of 1.95 and an average of 2.55, with values ranging from -21.27 to 16.42. Profitability is similarly varied: ROE median is 10.77 and average is 15.32 across 197 companies, while ROCE median is 13.35 and average is 17.69.
Because the supplied dataset does not provide company-specific P/E, P/B, ROE or ROCE for Neuland Laboratories Ltd., the most reliable sector reading comes from scale and benchmark dispersion. The Healthcare universe includes both relatively small listed names and a long tail of valuation outcomes, which means stock-specific moves can occur within a very wide market structure. In Market Movers analysis, that matters because a large-cap stock rising 3.02% is not the same as a thinly traded small counter doing the same.
The benchmark’s largest company is shown at Rs 3,060.41 crore, while Neuland Laboratories Ltd. Market Cap is Rs 25,614.49 crore. That alone sets the company apart from the supplied benchmark constituents and explains why today’s price rise has drawn interest. From a Univest perspective, the stock is not just moving higher; it is doing so from a materially larger capital base than the sector comparison group presented here.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 3,060.41 | 31.3 | 0.46 | -2.89 | -0.26 |
| Hikal Ltd. | HIKAL | 2,862.43 | 0 | 2.29 | 15.22 | 16.15 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,652.52 | 40.87 | 8.32 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,623.92 | 67.31 | 10.65 | 18.65 | 22.17 |
| Panacea Biotec Ltd. | PANACEABIO | 2,571.92 | 0 | 3.06 | 0 | 5.36 |
Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 25,614.49 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
The peer list supplied with this Neuland Laboratories Ltd. Stock News update includes 10 Healthcare names, mostly in Pharmaceuticals & Drugs, plus one Hospital & Healthcare Services company. Even without company-specific valuation ratios for Neuland Laboratories Ltd., the comparison set still helps frame today’s price rise in terms of relative market size and the valuation-profitability spread within the sector.
On market capitalisation, every listed peer in the supplied set is smaller than Neuland Laboratories Ltd. The largest peer shown is Dishman Carbogen Amcis Ltd. at Rs 3,060.41 crore, followed by Hikal Ltd. at Rs 2,862.43 crore and Kwality Pharmaceuticals Ltd. at Rs 2,652.52 crore. Beta Drugs Ltd. is at Rs 2,623.92 crore and Panacea Biotec Ltd. at Rs 2,571.92 crore. Neuland Laboratories Ltd. at Rs 25,614.49 crore is therefore multiple times larger than any peer in this list, which makes the 3.02% share price gain more notable from a capital-weighted perspective.
The peer valuation range is also broad. Reported P/E values include 31.3 for Dishman Carbogen Amcis, 40.87 for Kwality Pharmaceuticals, 67.31 for Beta Drugs, 167.74 for Sai Parenteral’s, 46.11 for Fredun Pharmaceuticals, 44.1 for NGL Fine-Chem and 33.29 for Dr Agarwals Eye Hospital. That spread reinforces how uneven pricing can be inside the Healthcare basket.
Profitability among peers is equally mixed. ROE ranges from -2.89 at Dishman Carbogen Amcis and -2.6 at Dr Agarwals Eye Hospital to 28.21 at Kwality Pharmaceuticals and 27.9 at NGL Fine-Chem. ROCE ranges from -0.26 at Dishman Carbogen Amcis to 33.91 at NGL Fine-Chem, with Beta Drugs at 22.17 and Kwality Pharmaceuticals at 26.35. In other words, the peer group includes both loss-making and high-return businesses, so simple sector labels are not enough to explain stock performance.
For investors tracking Neuland Laboratories Ltd. Share News, the practical takeaway is that today’s price rise occurred in a company whose market size sits well above the peer basket supplied here. That does not answer valuation questions on its own, but it does show why this stock can draw more attention in Indian Stock Market coverage when it appears among top gainers.
Why Investors Are Watching Neuland Laboratories Ltd.
Neuland Laboratories Ltd. Share Price is being watched because the stock recorded a verified 3.02% same-day gain, stayed near its intraday high and did so from a large-cap base of Rs 25,614.49 crore. In event-driven Stock Updates, that combination is enough to move the counter into the active watchlist even without a confirmed company-specific trigger.
- Verified price action: the stock rose Rs 650.05 from Rs 21,499.95 to Rs 22,150.
- Intraday range: it opened at Rs 21,544.2, hit a high of Rs 22,225 and the low was also Rs 21,544.2.
- Trading activity: total volume reached 1,13,373 shares and turnover stood at Rs 11.33 crore.
- Market-cap context:<
- Sector position: its market capitalisation is far above the supplied Healthcare benchmark medians and averages.
What investors may monitor next is whether Neuland Laboratories Ltd. Share Price Today continues to hold close to the day’s upper range, whether trading interest remains active across NSE and BSE, and how the stock behaves relative to Healthcare peers and broader sector sentiment. Univest is focusing on the verified relationship between price, scale and trading participation rather than assuming an unconfirmed cause for the move.
About Neuland Laboratories Ltd.
Based on the supplied dataset, Neuland Laboratories Ltd. is classified within the Healthcare sector. That sector tag places the company inside one of the most actively tracked groups in the listed Indian market, alongside pharmaceutical, drug and healthcare-service businesses shown in the benchmark and peer set.
The surrounding comparison universe in this article includes companies such as Dishman Carbogen Amcis, Hikal, Kwality Pharmaceuticals, Beta Drugs, Panacea Biotec, Solara Active Pharma Sciences and NGL Fine-Chem. Most of those businesses are categorised under Pharmaceuticals & Drugs, while Dr Agarwals Eye Hospital is classified under Hospital & Healthcare Services. This gives readers a practical sense of the market environment in which Neuland Laboratories Ltd. Share Price is being tracked today.
What stands out most from the supplied information is scale. With a market capitalisation of Rs 25,614.49 crore, the company is substantially larger than both the benchmark median and the peer set presented here. That is why even a 3.02% price rise becomes notable in Market Update coverage. In Univest coverage, the company’s present significance comes less from a claimed narrative catalyst and more from the verified combination of size, sector relevance and a meaningful single-session move.
Track Neuland Laboratories Ltd. Share Price on Univest
Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.
Readers following Neuland Laboratories Ltd. Share Price can use Univest to keep track of live price moves, daily percentage changes, market capitalisation, 52-week levels, shareholding pattern updates when available, and broader market insights. For active users, that makes it easier to place a same-day move like today’s 3.02% rise inside a wider stock analysis framework.
Univest also helps users compare listed stocks across sector context, peer positioning, volume trends and headline-driven market developments. When a stock appears in event screens such as top gainers, the value is not only in seeing the price change but also in understanding the market-cap backdrop and how the move compares with the broader Healthcare universe. That is where a structured Univest workflow adds context to Neuland Laboratories Ltd. Latest News.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Neuland Laboratories Ltd. Share Price today?
Ans. Neuland Laboratories Ltd. Share Price today was Rs 22,150 at the time of this update. The stock was up 3.02% from the previous close of Rs 21,499.95, reflecting a same-day gain of Rs 650.05.
Why is Neuland Laboratories Ltd. Share Price rising today?
Ans. The supplied data confirms that Neuland Laboratories Ltd. Share Price rose 3.02% today and cleared the event threshold for its Large Cap category. The dataset establishes the price move and trading activity, but not a company-specific catalyst.
How much did Neuland Laboratories Ltd. gain in today’s session?
Ans. The stock gained Rs 650.05 in absolute terms during the session covered here. Neuland Laboratories Ltd. Share Price moved from the previous close of Rs 21,499.95 to Rs 22,150, which translates into a 3.02% rise.
What were the day high, day low and opening price?
Ans. Neuland Laboratories Ltd. opened at Rs 21,544.2, touched an intraday high of Rs 22,225 and recorded a day low of Rs 21,544.2. The trading range shows the stock moved higher after the open and stayed firm.
What is the market capitalisation of Neuland Laboratories Ltd.?
Ans. The company’s market capitalisation is Rs 25,614.49 crore based on the supplied data. That makes Neuland Laboratories Ltd. much larger than the Healthcare benchmark median of Rs 140.58 crore and average of Rs 471.12 crore.
How much volume was traded in Neuland Laboratories Ltd. today?
Ans. Total traded volume stood at 1,13,373 shares in this update. Of that, BSE volume was 5,113 shares and NSE volume was 1,08,260 shares, while turnover for the session reached Rs 11.33 crore.
Is Neuland Laboratories Ltd. a large-cap stock?
Ans. Yes, the stock is categorised as Large Cap in the supplied event data. That classification matters because today’s 3.
Which sector does Neuland Laboratories Ltd. belong to?
Ans. Neuland Laboratories Ltd. is classified in the Healthcare sector in the supplied dataset. The benchmark comparison used here covers 198 companies in the same sector, highlighting valuation, profitability and market-cap dispersion across Healthcare stocks.
How does Neuland Laboratories Ltd. compare with the supplied peers on size?
Ans. Neuland Laboratories Ltd. is larger than every peer listed in the supplied comparison set. Its market capitalisation is Rs 25,614.49 crore, while the largest named peer, Dishman Carbogen Amcis, stands at Rs 3,060.41 crore.
What should investors monitor after today’s move?
Ans. Investors may track whether Neuland Laboratories Ltd. Share Price holds near the upper end of today’s range, whether turnover remains active after Rs 11.33 crore, and how the stock behaves relative to Healthcare peers and broader market sentiment.
